Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2025

The Application of iPSCs in Tumour Immunotherapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPeinan ChenJGJian GaoJFJianfeng Feng

Discussion

Loading...

Member takes

Overview

Comprehensive review shows how ips cells enhance active and adoptive immunotherapy for tumours, highlighting challenges.

Key Points

  • Induced pluripotent stem cells (ips cells) are pivotal in developing both active and adoptive immunotherapy for cancer treatment.
  • Active immunotherapy uses cancer vaccines to stimulate the immune system, while adoptive immunotherapy involves using modified immune cells.
  • Ips cells can be easily gene edited and differentiated into immune cells, allowing versatile applications in tumour immunotherapy.
  • This review discusses the potential of ips cells in creating ready-to-use immunotherapy products and the challenges faced in the field.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/689e03e0d61984b91e13cf48https://doi.org/10.1017/erm.2025.10006
View Full Paper
Ask AI
Bookmark
Share